Hagerty Reports Third Quarter 2026 Results; Increases 2026 Growth Outlook

For the nine months ended September 30, 2026, Hagerty grew written premium 18% to $1.099 billion, added a record 402,000 members, and increased Adjusted EBITDA 43% to $257 million; operating cash flow rose 48% to $280 million. GAAP net income fell to $32 million from $121 million, including $189 million of pre-tax transitional costs tied to the Markel Fronting Arrangement, while reported revenue declined 7% to $1.021 billion partly because of the arrangement’s accounting treatment. Hagerty raised full-year 2026 net income guidance to $48–$60 million from $18–$30 million and Adjusted EBITDA guidance to $305–$315 million from $270–$280 million.

Analysis

The key underwriting signal is less strong than the headline combined ratio suggests: the 85.2% year-to-date ratio includes $32 million of favorable loss-estimate revisions. Relative to earned premium, that is roughly 4 points of benefit; stripping it out puts the ratio near 89%, broadly in line with the prior-year 89.3%. The thesis therefore rests more on premium growth and the new economics than on demonstrated improvement in current-period loss performance. Also, the move to 100% quota share increases Hagerty Re’s retained economics and risk; the reported growth in assumed premium is partly a change in risk share, not purely organic demand.

Reported revenue is a poor near-term read-through because intercompany commissions disappear under the new structure. Adjusted EBITDA better reflects management’s view of operating momentum, but its growth excludes substantial transition amortization and should not be treated as equivalent to cash earnings attributable to HGTY shareholders. The large gap between consolidated earnings metrics and Class A earnings, alongside a much larger fully converted share count, makes per-share conversion an important diligence item.

The near-term catalyst is the expected runoff of transition costs in Q4, which may lift GAAP earnings but is largely anticipated. Over 1–3 months, test whether growth persists without further reserve releases and whether retention stabilizes. Over 6–18 months, higher retained underwriting exposure creates greater sensitivity to claims inflation, adverse development, and reinsurance execution. The contrarian opportunity is that accounting-driven revenue and net-income declines may obscure improved underlying economics—but the bullish case is not validated until loss performance holds without reserve tailwinds.

Key Decisions for Investors

• Do not trade the revenue decline as evidence of demand deterioration; it is materially affected by the Markel structure and consolidation eliminations. Use written premium, retention, and normalized loss performance instead.
• Treat HGTY as a conditional long/watch, not a chase: consider entry after the earnings-call reaction only if management’s explanation supports stable underlying combined ratios excluding favorable reserve development. No valuation or price data is provided to set an entry level or target.
• Set a thesis alert for retention falling further or the combined ratio excluding reserve releases moving persistently above roughly 90%; either would weaken the growth-plus-underwriting-quality case and argue against adding exposure.
• Do not infer a direct negative trade in MKL from the arrangement: the economics and risk allocation changed, but the supplied information does not establish a material consolidated earnings impact for Markel Group.